Reversing the Youth Tobacco Epidemic Act of 2019 This bill revises requirements related to the safety, sale, and advertisement of tobacco products, including electronic nicotine delivery systems (e.g., e-cigarettes, e-hookah, e-cigars, and vape pens). Among other requirements, the bill requires the Food and Drug Administration (FDA) to implement regulations to require color graphics on the labeling of cigarette packages, depicting the negative health consequences of smoking; requires the FDA to apply regulations on tobacco products to all tobacco products, including e-cigarettes; prohibits the retail online sale of tobacco products, including electronic nicotine delivery systems; prohibits flavors other than tobacco in a tobacco product; prohibits the use of flavored products in an electronic nicotine delivery system, except in specified circumstances; increases the user fees that the FDA collects from manufacturers and importers; directs the FDA to regulate products containing synthetic nicotine (not made or derived from tobacco); establishes a demonstration grant program to develop strategies for smoking cessation in medically underserved communities; increases civil penalties for certain violations of restrictions on the sale of tobacco products; and requires the Government Accountability Office to study e-cigarettes.
Administrative law and regulatory proceduresChild healthCivil actions and liabilityCongressional oversightConsumer affairsDepartment of Health and Human ServicesDrug, alcohol, tobacco useDrug safety, medical device, and laboratory regulationFood and Drug Administration (FDA)Government information and archivesGovernment studies and investigationsHealth care coverage and accessHealth programs administration and fundingHealth promotion and preventive careMarketing and advertisingMental healthMinority healthRacial and ethnic relationsRetail and wholesale tradesState and local government operationsUser charges and fees
Reversing the Youth Tobacco Epidemic Act of 2020
USA116th CongressS-3174| Senate
| Updated: 1/9/2020
Reversing the Youth Tobacco Epidemic Act of 2019 This bill revises requirements related to the safety, sale, and advertisement of tobacco products, including electronic nicotine delivery systems (e.g., e-cigarettes, e-hookah, e-cigars, and vape pens). Among other requirements, the bill requires the Food and Drug Administration (FDA) to implement regulations to require color graphics on the labeling of cigarette packages, depicting the negative health consequences of smoking; requires the FDA to apply regulations on tobacco products to all tobacco products, including e-cigarettes; prohibits the retail online sale of tobacco products, including electronic nicotine delivery systems; prohibits flavors other than tobacco in a tobacco product; prohibits the use of flavored products in an electronic nicotine delivery system, except in specified circumstances; increases the user fees that the FDA collects from manufacturers and importers; directs the FDA to regulate products containing synthetic nicotine (not made or derived from tobacco); establishes a demonstration grant program to develop strategies for smoking cessation in medically underserved communities; increases civil penalties for certain violations of restrictions on the sale of tobacco products; and requires the Government Accountability Office to study e-cigarettes.
Administrative law and regulatory proceduresChild healthCivil actions and liabilityCongressional oversightConsumer affairsDepartment of Health and Human ServicesDrug, alcohol, tobacco useDrug safety, medical device, and laboratory regulationFood and Drug Administration (FDA)Government information and archivesGovernment studies and investigationsHealth care coverage and accessHealth programs administration and fundingHealth promotion and preventive careMarketing and advertisingMental healthMinority healthRacial and ethnic relationsRetail and wholesale tradesState and local government operationsUser charges and fees